Research Articles
Unlocking Cancer Cell Suicide: How a New Chemical Fights Colon Cancer
Discover how a new benzoindole derivative triggers apoptosis in colon cancer cells, offering a promising targeted therapy approach.
Disrupting Cancer's Command Center: Halting Tumor Growth by Targeting Protein-DNA Interactions
Explore how disrupting protein-DNA interactions offers new opportunities for cancer chemotherapy through precision medicine approaches.
Catching Cancer in the Act: How a Molecular Fishhook Could Revolutionize Detection
Explore how immunotargeted PET imaging of TEM1/Endosialin is revolutionizing cancer detection and monitoring through molecular precision.
Plasmid-Lipid Complexes: A Precision Strike Against Cancer
Revolutionary cancer therapy using plasmid-lipid complexes for direct intratumoral injection, converting tumors into personalized vaccine factories.
Revolutionizing Cancer Care: How AI, Immunotherapy, and Gene Editing Are Changing the Game
Explore how AI, immunotherapy, and gene editing are transforming cancer diagnostics and treatment through precision medicine approaches.
The Hidden Fuel: How Cancer Hijacks the Body's Metabolism
Exploring how cancer reprograms metabolism through elevated glucose, triglycerides, and liver enzymes in DMBA-induced rat carcinogenesis
A Double-Barreled Shotgun for Cancer: Supercharging Chemotherapy with a New Two-in-One Drug
Discover how PTUPB, a dual COX-2/sEH inhibitor, enhances cisplatin's effectiveness against resistant cancers while potentially reducing side effects.
Unlocking Cancer's Secrets: How a Quantum Computer Might Find Tomorrow's Cures
Exploring how quantum chemistry and bioinformatics are revolutionizing cancer research through selectin polymorphisms analysis.
Lighting the Path: How Glowing Molecules Could Revolutionize Cancer Treatment
Explore how chromene–triazole–coumarin triads as fluorescent CDK inhibitors are transforming cancer treatment through combined therapy and diagnostics.
The Insulin-Linked Shield: How Cancers Outsmart Targeted Drugs
Understanding how cancers develop resistance to irreversible EGFR tyrosine kinase inhibitors through the IGF1R pathway and multistep survival strategies.